A novel floating controlled release drug delivery system prepared by hot-melt extrusion

被引:76
作者
Vo, Anh Q. [1 ]
Feng, Xin [1 ]
Morott, Joseph T. [1 ]
Pimparade, Manjeet B. [1 ]
Tiwari, Roshan V. [1 ]
Zhang, Feng [2 ]
Repka, Michael A. [1 ,3 ]
机构
[1] Univ Mississippi, Sch Pharm, Dept Pharmaceut & Drug Delivery, University, MS 38677 USA
[2] Univ Texas Austin, Coll Pharm, Austin, TX 78712 USA
[3] Univ Mississippi, Pii Ctr Pharmaceut Technol, University, MS 38677 USA
关键词
Hot-melt extrusion; Foamed extrudate; Floating drug delivery system; Controlled release; Eudragit (R) RSPO; Chemical imaging; Theophylline; PROLONGED GASTRIC RESIDENCE; MULTIPLE-UNIT SYSTEM; IN-VITRO; PHARMACEUTICAL APPLICATIONS; MATRIX TABLETS; DOSAGE FORMS; PELLETS;
D O I
10.1016/j.ejpb.2015.11.015
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Floating dosage forms are an important formulation strategy for drugs with a narrow absorption window and low intestinal solubility, and for localized gastric treatment. Novel floating pellets were prepared using the hot-melt extrusion (HME) technology. Uniformly foamed strands were created by liquid injection pumping and screw configuration modification. The ammonio methacrylate copolymer (Eudragit (R) RSPO) foaming structure was formed by a liquid vapor phase transition inside the strand upon die exiting resulting from the sudden decrease in external pressure, vaporizing the liquid ethanol and vacating the extruded material. This generated uniform vacuous regions in the extrudate. The pellets' internal structure was investigated using scanning electron microscopy (SEM). The formulation constituents' and processing parameters' effects on the drug release profiles, floating force, and the pellets' micromeritic properties were evaluated by design of experiments: all formulations showed zero lag time and excellent floating strength, indicating immediate-floating pellet formation. The pellets' drug release profiles were controlled by multiple independent variables at different time points (<= 24 h). Drug loading significantly affected drug release within the first hour, the hydroxypropyl methylcellulose (HPMC) content thereafter. Understanding the variables' effects on the formulations allows for the tailoring of this delivery system to obtain various drug release profiles. (C) 2015 Elsevier B.V. All rights reserved.
引用
收藏
页码:108 / 121
页数:14
相关论文
共 32 条
[1]   Floating lipid beads for the improvement of bioavailability of poorly soluble basic drugs: In-vitro optimization and in-vivo performance in humans [J].
Abouelatta, Samar M. ;
Aboelwafa, Ahmed A. ;
Khalil, Rawia M. ;
EIGazayerly, Omaima N. .
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS, 2015, 89 :82-92
[2]  
Armstrong N. A., 2006, PHARM EXPT DESIGN IN, P121
[3]   Floating drug delivery systems: A review [J].
Arora, S ;
Ali, J ;
Ahuja, A ;
Khar, RK ;
Baboota, S .
AAPS PHARMSCITECH, 2005, 6 (03) :E372-E390
[4]   Optimisation of floating matrix tablets and evaluation of their gastric residence time [J].
Baumgartner, S ;
Kristl, J ;
Vrecer, F ;
Vodopivec, P ;
Zorko, B .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2000, 195 (1-2) :125-135
[5]   Melt extrusion: from process to drug delivery technology [J].
Breitenbach, J .
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS, 2002, 54 (02) :107-117
[6]   Adsorption of gases in multimolecular layers [J].
Brunauer, S ;
Emmett, PH ;
Teller, E .
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 1938, 60 :309-319
[7]   Pharmaceutical applications of hot-melt extrusion: Part I [J].
Crowley, Michael M. ;
Zhang, Feng ;
Repka, Michael A. ;
Thumma, Sridhar ;
Upadhye, Sampada B. ;
Battu, Sunil Kumar ;
McGinity, James W. ;
Martin, Charles .
DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY, 2007, 33 (09) :909-926
[8]   Physiological relevant in vitro evaluation of polymer coats for gastroretentive floating tablets [J].
Eisenaecher, Friederike ;
Garbacz, Grzegorz ;
Maeder, Karsten. .
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS, 2014, 88 (03) :778-786
[9]  
Garg R, 2008, TROP J PHARM RES, V7, P1055
[10]   Air compartment multiple-unit system for prolonged gastric residence. Part II. In vivo evaluation [J].
Iannuccelli, V ;
Coppi, G ;
Sansone, R ;
Ferolla, G .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1998, 174 (1-2) :55-62